NV Industriebank LIOF
VC Fund
Maastricht, The Netherlands
NV Industriebank LIOF is a VC fund in Maastricht focused on Biotechnology and Medical. NV Industriebank LIOF is the Limburg development and investment company. LIOF contributes to the prosperity of the province with an ongoing program to strengthen the province's economic base. LIOF targets industry and the dynamic service sector.Its four core activities are Acquisition, Participation, Development/Innovation andBusiness Parks, as these relate to the location/relocation of (foreign) companies, venture capital participation in Limburg companies with prospects, the development/implementation of programs and projects to sharpen the competitive edge of Limburg business and the coordination of the development of new business parks.LIOF has a strategic approach which targets opportunities for long-term economic development. In this it has a bridging role between government and business. LIOF is an ambitious professional organization and speaks the language that business understands.
- Total investments:
- 28
- Last investment:
- Lead investor:
- 29%
Last updated:
For AI agents: llms.txt
Industries NV Industriebank LIOF invests in
Stages NV Industriebank LIOF invests in
Countries NV Industriebank LIOF invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
3 more contacts available
Investment Focus
Industry
- Biotechnology 7 (25%)
- Medical 6 (21%)
- Health Care 5 (18%)
- Manufacturing 4 (14%)
- Agriculture 3 (11%)
Stage
- Funding Round 7 (25%)
- Seed 5 (18%)
- Series A 5 (18%)
- Venture - Series Unknown 4 (14%)
- Series B 3 (11%)
Country
- The Netherlands 21 (75%)
- Belgium 1 (4%)
- Germany 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
John Vossen
Investment Manager
|
Investment Manager | Total investments: 1 | Find email | |
Tys van Elk
Managing Director / CEO
|
Managing Director / CEO | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Pegasus Materials
|
Pegasus Materials uses a combination of synthetic biology and chemistry to engineer bio-based materials for applications. | Seed / Nov 20, 2025 | |
|
Pegasus Materials
|
Pegasus Materials uses a combination of synthetic biology and chemistry to engineer bio-based materials for applications. | Seed / Nov 27, 2024 | |
SpecifAi Parking
|
The SpecifAi Parking intelligence platform securely centralises and integrates parking data from numerous sources, presenting it in easy-to-understand dashboards. It leverages this information to provide predictive insights, allowing users to run their businesses more efficiently and effectively. | Venture - Series Unknown / Sep 10, 2024 | |
|
SpecifAi Parking
|
The SpecifAi Parking intelligence platform securely centralises and integrates parking data from numerous sources, presenting it in easy-to-understand dashboards. It leverages this information to provide predictive insights, allowing users to run their businesses more efficiently and effectively. | Venture - Series Unknown / Sep 10, 2024 | |
Mosa Meat
|
Mosa Meat produces slaughter-free hamburgers. The burger is harvested from cow cells, rather than raising and slaughtering a whole animal. By growing meat naturally from cells, Mosa Meat strives to accelerate the transition to a truly sustainable global food system. | $42.5M / Venture - Series Unknown / Apr 16, 2024 | |
Ansana
|
Ansana develops sterilization solutions for the pharmaceutical and healthcare industries. This technology is significantly cutting patient risk, reducing the environmental imprint, lowering expenses, and increasing flow. | $933.2K / Seed / Dec 19, 2023 | |
Corporis Medical
|
Corporis Medical is a young medical device company. They develop and commercialize innovative medical devices. They also lower the costs associated with surgery and surgical procedures for surgeons. They improve access, closure and diagnostic measurements. | $4.3M / Series B / Dec 07, 2023 | |
MLA Diagnostics
|
MLA Diagnostics is developing the Ly75 indicator, a prognostic biomarker that can effectively predict patients’ clinical outcomes. Moreover, the marker is inexpensive, robust, and efficient. Based on the outcome of the MLA Diagnostics biomarker test, patients and physicians can together choose a more effective and personalised treatment path. | Venture - Series Unknown / Nov 29, 2023 | |
Embrosa
|
Embrosa specializes in delivering marketing content from the brand's HQ to local retailers across the globe. | $498.1K / Seed / May 03, 2023 | |
ToxGenSolutions
|
(Epi-)genetic approaches addressing molecular initiation events and key events of adverse outcome pathways driving pathologies like neurodegeneration, cancer and immune-dysfunction. | $52.6K / Grant / Dec 11, 2022 | |
| See all 28 investments → | |||
Co-Investors
Brightlands Venture Partners
7 deals together
Limburg Ventures
5 deals together
Lumana Invest
3 deals together
Nedermaas Hightech Ventures
3 deals together
Chemelot Ventures
2 deals together
Fibrant
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does NV Industriebank LIOF invest in?
NV Industriebank LIOF invests primarily in Biotechnology, Medical and Health Care startups, most often at Funding Round and Seed stage. Most of the 28 investments tracked by Shizune back companies in The Netherlands. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact NV Industriebank LIOF?
Public channels for NV Industriebank LIOF include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at NV Industriebank LIOF?
The team at NV Industriebank LIOF includes John Vossen (Investment Manager) and Tys van Elk (Managing Director / CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
